Navigation Links
Taking Animals Out of Laboratory Research

Pioneering work to reduce the use of animals in scientific research and ultimately remove them from laboratories altogether has received a major boost at The University of Nottingham.

A laboratory devoted to finding effective alternatives to animal testing has been expanded and completely remodelled in a 240,000 overhaul designed to hasten the development of effective non-animal techniques.

Scientists hope that by developing the use of cell and tissue cultures, computer modelling, cell and molecular biology, epidemiology and other methods, they will one day be able to completely remove animals from medical research while still maintaining crucial work to defeat diseases that affect millions of people.

The new FRAME Alternatives Laboratory, within the University's Medical School, is to be officially opened by Ed Balls MP, Economic Secretary to the Treasury, on July 6.

FRAME Fund for the Replacement of Animals in Medical Experiments has had its laboratory at the University for 25 years, making Nottingham unique as the location of the charity's only research facility. The lab is run as a FRAME/University collaboration.

FRAME advocates the use of alternative methods to animal testing, through the use of the 'Three Rs' refinement, reduction and replacement. Refinement of procedures so that the suffering of any animals necessarily used is minimised, reduction of the number of animals used to an unavoidable minimum, and ultimately replacement of animals altogether with validated alternative methods such as cell cultures and computer modelling.

The charity is seeking reliable, scientifically proven ways forward which take account of the welfare of both humans and animals, without jeopardising the ground-breaking work on the major healthcare challenges of the 21st century taking place at research centres around the world.

The official opening of the new FRAME Alternatives
'"/>




Page: 1 2 3

Related medicine news :

1. Taking the help of pharmacist
2. Taking Care Of Grandkids Can Give Women more than a Headache
3. Taking Vitamin Supplements With Caution
4. Trust In Doctors Can Affect Taking Medications
5. In The Habit Of Taking Painkillers For Your Chronic Headache? Time To Switch Over
6. Teenagers Take More Risk-Taking Behaviors In The Company Of Same Sex Friends
7. Taking Music Lesson To Reduce Stress
8. Not Taking Drugs Made Kate Winslet A Misfit
9. Task Learning Made Simple By Taking Short Breaks
10. Heart Patients Taking Anti-depressants Have Higher Risk Of Death
11. Chirps of Wisdom: Taking a Leaf out Of Vietnam’s Bird-Flu Sag
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...ted by scientists at Wageningen University, Nether...s Vitamin B6) can slow down the cognitive decline ... has been known to help in the brain development o...long time now. Due to this reason it is administer...
...iscovered the key molecule that gets over activate...sets way for the condition to be expressed. Huntin...stroys the ability of the person to think or move ...e may be depression, mood swings, forgetfulness, a...
...ly issued a warning regarding the consumption of L...y contain glyburide - a drug that could have serio...The warning from the FDA has come after they learn...consumer complaint which was followed up with test...
...e able to stop the geriatric population from falli...aintain their balance. The device is called Yaktra...hat conforms to the footwear and helps the people ...g a stable walk that will prevent falls. Research...
Other Medicine News:
(Date:9/3/2008)... Company to Discuss Phase 3 Plans with...ile Therapeutics, Inc.,announced today that it su...e development of the company,s new, innovative low... company refers to by its internal product,code AG...ccessfully met its,primary endpoint of ovulation s...
(Date:9/3/2008)... SB-509 to be Evaluated in Repeat-Dosing Study in ...ewswire-FirstCall/ -- Sangamo,BioSciences, Inc. (N...a Phase,2 clinical trial (SB-509-801) to evaluate ...ive, degenerative motor-neuron disease for which t...Sangamo,s drug, SB-509, is an injectable formulati...
(Date:9/2/2008)...PARIS, September 3 /-, - T...ecreased the Risk,of Stroke by 34% in Patients Wit...equately Treated by Antithrombotic Therapy, The r... ATHENA study,were presented today at the clinical...ardiology congress 2008, in Munich, Germany. Previ...
(Date:9/2/2008)...HARRISBURG, Pa., Sept. 2 /PRNewswire-USNewswire/ -...ild animals is underway in western,Pennsylvania, A...e oral rabies vaccination baiting program covers a...r, Crawford, Erie, Fayette, Greene,Indiana, Lawre...counties., "Controlling the spread of rabies in w...
Breaking Medicine Technology:Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Rabies Vaccination Program Underway in Western Pennsylvania 2DHHS Guidelines Support Use of Trofile 28TM 29 Assay Prior to CCR5 Inhibitor Use 1303 1DHHS Guidelines Support Use of Trofile 28TM 29 Assay Prior to CCR5 Inhibitor Use 1303 2DHHS Guidelines Support Use of Trofile 28TM 29 Assay Prior to CCR5 Inhibitor Use 1303 3DHHS Guidelines Support Use of Trofile 28TM 29 Assay Prior to CCR5 Inhibitor Use 1303 4DHHS Guidelines Support Use of Trofile 28TM 29 Assay Prior to CCR5 Inhibitor Use 1303 52007 Another Record Year in Terms of Sales and Earnings for Gerresheimer 2952 12007 Another Record Year in Terms of Sales and Earnings for Gerresheimer 2952 22007 Another Record Year in Terms of Sales and Earnings for Gerresheimer 2952 3Smart holograms help patients help themselves 2104 1Smart holograms help patients help themselves 2104 2American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema 10816 1American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema 10816 2American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema 10816 3American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema 10816 4
...2007 /PRNewswire-FirstCall/ -- Boston,Scientific C...ticle,in the Journal of of Cardiology (JACC) revie...es the Company,s second-generation,TAXUS(R) Libert...cle in the April 24 edition of JACC concluded that... of the TAXUS Liberte Stent,system compared to the...
...ata Presented at ASCO -, CHICAGO, June 04, 2007 /P...ay that Soliris(TM) (eculizumab), a new treatment ...loped by Alexion,Pharmaceuticals, Inc. , is effect...ory of aplastic anemia (AA) or myelodysplastic,syn...ood cell,destruction (hemolysis), decreased or eli...
Other Medicine Technology:Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 2Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 3Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 4Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 2Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 3Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 4Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 5Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 6Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 7
...iCharts, is a state-of-the-art electronic medical ...8. It is a proven, comprehensive electronic medica...are providers at the point of care and to be share...nternet. AmkaiCharts chronicles patient history, e...
...fice seamlessly integrates practice management and...nd clinical workflow. Instantly access registratio...eporting information for multiple practices, provi...tely improves productivity by simplifying office w...
The ReSeeVit Slit Lamp System is an easy-to-use digital video imaging system that captures anterior segment and retinal images for documentation, diagnosis and patient education. The package includes
...e is an important movement in our country to provi...ns. In fact, recent government regulations require...s device affords your wheelchair-bound patients ea...t without having to leave their wheelchair. , ,The...
Medicine Products: